The Cannabis Society Executive Business Conference - Berlin (Invite Only)
Markgrafenstraße 33, 10117 Berlin, Germany
The Cannabis Society is proud to present our Executive Business Conference on February 13th in Berlin.
We are dedicated to fostering the cannabis community through events, conferences, dinners, & many more. Join us for a unique deal making session and to hear from Industry experts, entrepreneurs, investors and service providers on what is to come in this emerging industry.
9:30 AM - Registration10:30 AM - Opening Remarks10:45 AM - Keynote by Dentons11:15 AM - Panel: Regulations12:00 PM - BREAK12:45 PM - Panel: Research & Clinical Trials1:30 PM - Panel: Distribution2:15 PM - Panel: Combatting the Black Market3:00 PM - Networking
Dr. Knud Gastmeier
Marguerite Arnold, Co-Founder, CannaClear
A well known American expat industry journalist and tech entrepreneur with a 30 plus year background in all the areas that count.
Jens Kramer, VP Europe operations, Avicanna Inc.
An essential leader in driving business growth, efficiency and transformational initiatives, Jens has provided strategic counsel and operational guidance to several startup companies in Berlin. Previously, he has been responsible for design and implementation of scale-up plans for companies entering new markets and has successfully launched services in several countries. Capable of quickly assessing and identifying levers for driving potential distribution opportunities in Europe, Jens brings with him valuable entrepreneurial experience and region-specific expertise to Avicanna’s team with direct accountability for consistently delivering business objectives through multiple market sectors across Europe. He has attained his Bachelor of International Management from ISM University and has pursued his International Masters in Management from EADA Business School in Barcelona.
Franziska Katterbach, Managing Director and Chief Legal Officer, Khiron Life Sciences Europe
Franziska Katterbach is an accomplished business executive and legal expert with extensive experience in Europe’s emerging cannabis industry. Franziska joined corporate law firm Dentons, where she was involved in high-profile deals in the cannabis sector across multiple jurisdictions. Prior to joining Khiron, Franziska was Director of Legal for Canopy’s European operations.
Khiron Life Sciences Corp. is becoming the dominant integrated cannabis company in Latin America. Khiron is fully licensed in Colombia for the cultivation, production, domestic distribution and international export of both THC and CBD medical cannabis. Khiron delivers best in class regulatory compliance, has the first approved set of CBD cosmetic products on shelf in Colombia and has completed the EU cosmetic regulatory process. We’re currently facilitating testing to meet and surpass all license requirements for commercial cannabis derived products. Khiron combines global scientific expertise, agricultural advantages, branded product market entrance experience and education to drive prescription and brand loyalty.
Linus Weber, Founder & CEO at Nimbus Health GmbH
Linus Maximilian Weber is an experienced Business Consultant, Founder and Chief Executive in the health care industry. Linus has been working at Ernst & Young in the Compliance and Quality Management Consulting unit prior joining Fresenius Medical Care the worlds leading company in renal care. He is a certified Project Management Consultant and GDP Responsible for the pharmaceutical distribution business. In 2018 after building the Compliance Management System at Fresenius he founded Nimbus Health a fully licensed pharmaceutical wholesaler in Germany, where he serves as Chief Executive Officer. The focus of Nimbus Health is to improve the wellbeing of patients by giving consistent and standardized access to alternative therapies based on Medicinal Cannabis and to reshape the health care system by developing additional Cannabis products.
Dean Billington, COO, Brains Bioceutical
Dean Billington is COO of Brains Bioceutical, a leading GMP-certified producer and distributor of naturally sourced Active Pharmaceutical Ingredients (API). Mr. Billington began his career working with pharmaceutical CBD as an executive at GW Pharma. Dean brings a wealth of experience in the global pharmaceutical industry having held previous senior leadership positions, including Global QA at Caligor Rx and Director at Fisher Clinical Services for over six years. Mr. Billington holds a BSc in Chemical Engineering and Applied Chemistry from Huddersfield University.
Peter Homberg, Partner, Dentons
Peter Homberg is a partner in the Dentons Berlin office. He focuses on life sciences, IP, corporate law and M&A transactions in the life sciences and high-tech sector as well as in R&D and cooperation agreements, cross-border IP licensing and IP strategies. Furthermore, he has extensive experience providing legal advice on compliance issues. Additionally, he is the head of the European Cannabis sector group. Peter advises inter alia companies in the pharmaceutical, diagnostics, biotechnology, medical device and medical cannabis industries—from startups to large publicly listed companies. Furthermore, he has broad transactional experience in Southeast Asia. Peter is member of the Licensing Executive Society (LES), the German Association for Intellectual Property and Copyright (GRUR), the German Institution for Arbitration (DIS) as well as the Pharma-Lizenz-Club Deutschland e.V. He regularly holds lectures at seminars and conferences. He is the author of numerous professional articles and other publications regarding corporate or IP law in the field of life sciences.
Simon Tankel, President, Wundr Co.
Simon is the President of Wundr. His previous cannabis experience includes founding Golders Hill (merged into Wundr), Ark Wellness and an investment practice for a family office. Previously, he was Head of Business Development at Sum International, focusing on power plant development and latterly cannabis investing.
Dr. Constantin von der Groeben, Managing Director, DEMECAN
Dr. Constantin von der Groeben is a co-founder and managing director of DEMECAN, and leads the company’s legal and regulatory affairs department. Under his direction, DEMECAN’s Joint Venture with Canadian LP Wayland won Germany’s tender process on cannabis cultivation licenses. Dr. von der Groeben’s expertise lies in the regulatory framework of medicinal cannabis including EU-GMP, narcotics, and pharmaceutical law. He believes that smart regulation of medicinal cannabis will allow for the development of a genuine pharmaceutical product that will be widely accepted by doctors, patients, and society as a whole.
Boris Moshkovits, Co-founder and Managing Director, alephSana
Boris Moshkovits is a Cannapreneur and experienced founder with a demonstrated history of working in the media, pharma and internet industry. He is the co-founder and managing director of alephSana, a company focused on scouting for qualified medical cannabis products globally and on bringing the best cannabis therapeutics to Germany and Europe. Moshkovits has served as International digital marketing manager in the pharma industry walking the fine line of marketing and digital storytelling in highly regulated markets. As a speaker Moshkovits has been talking about the mainstreaming of medical cannabis and the future of cannabis as a lifestyle product. He is also the co-founder of the CannaBusinessClub.Berlin, an initiative to empower the local cannabis scene. In his publishing career, he was the head of digital media for Ringier Publishing Germany and publisher of Amuse for Vice Media Germany. Prior to this, he has worked as an editor and publisher in Milan, Moscow and New York.
Juriën Koster,Vice-President International Relations at Ofinext and Director at C.I.E.
Active in the cannabis industry since 2017. Help to build four different companies from the ground up. Actively developing a professional cannabis industry in The Netherlands and Europe. Occasional speaker at cannabis conventions and advisor to trade shows and events. Expertise in the technical and pharmaceutical aspects of the market.
International spokesperson for Ofinext. Building and maintaining a broad network of different stakeholders with a focus on the pharmaceutical aspect of the market. Developing our own Ofinext pharmaceutical products (EU-GMP certified full spectrum API's) and looking for new possibilities.Lead role in the Ofinext clinical trials. In charge of project management and making strategic decisions regarding the trials.Actively lobbying for the cannabis industry in Europe and most notably The Netherlands, by organizing cannabis events and the development of a scientific cannabis center in Wageningen.
Finn Age Hänsel, Founder & Managing Director, Sanity Group
Finn Age Hänsel, 36, studied Business Administration in Germany, Hungary and New Zealand. Following a 4-year engagement at BCG with focus on medical and health, he joined Rocket Internet in Australia from 2011 to 2013, as a Managing Director. After founding the largest australian online fashion retailer, THE ICONIC, he went on to become the Managing Director of the ProSiebenSat1-Incubator, EPIC Companies. In 2015 he founded the Berliner Berg brewery and became a Business Angel for multiple Berlin start-ups including CrossEngage, SMACC, Cars24 and Einhorn. After 4 years being CEO at the scale-up Movinga, Finn founded the Sanity Group, a European Cannabis company, together with Fabian Friede.
The 45-year-old trained editor with a bachelor's degree in marketing has a very close personal connection to the subject of medical cannabis. Therefore, after nearly 20 years working in the media and PR business, she dropped her own agency and joined Leafly.de. Since the launch of Leafly.de in May 2017, she has been an advocate for patients and a recognized contact for physicians and industry representatives. She has built up an extensive international network in all directions and has a lot of insider knowledge. Under her editorial guidance, Leafly.de has become the leading knowledge portal on cannabis as a medicine in the German-speaking European countries. With more than 300,000 visitors per month, the independent online portal is the number one source of information for physicians, patients and healthcare professionals. As an expert, she is often on the road to educate and inform people about the topic.
Emanuel Kotzian, CEO, Agentur Sowjet GmbH
For more than twenty years Emanuel Kotzian dedicates himself to the education about the effects of marihuana and lobbies for the re-normalization of this classic cultural plant. In 2000 he established Germany's biggest Cannabis-Magazine “Hanf Journal” and founded Agentur Sowjet GmbH, where he currently serves successful as its CEO. With more than 1 million fans, followers and readers on several channels, Agentur Sowjet is one of the leading marketing companies on the European Hemp Market. Its network of companies and branch offices extends from the Canary Islands to Kiev in the Ukraine and represents a unique platform for any market participant. Emanuel Kotzian was born 1972 in Krakow and immigrated with his family to Germany where he became a professing World-Citizen. After finishing High School in 1992 he studied Economics. Partly he was serving at a German court as a commercial judge, what did not stop him to get engaged into local politics. Now he is deeply involved in the promotion and up rise of CBD-Products, what he believes is a very important key for making hemp a normal and accepted natural product again."
Andrew Rosen, Head of Global Business Development, Cannatrek
Andrew Rosen is the Head of Global Business Development for Cannatrek, a medical cannabis company in Australia focused on superior cultivation and medical product development. He has assisted numerous companies in the cannabis industry to expand and strategize activities in international markets. He also holds a position as the Director of Strategic Partnerships for Cannamerx, the leading commodities exchange in the Cannabis and Hemp industry with over 250 members globally.
If you are an established national or international company, and are looking to learn more about the cannabis space, please reach out to email@example.com for more information.
***More information about the Cannabis Society here.
This listing has no upcoming events
General Admission - Last Chance
Service Providers (Lawyers, Accountants, Recruiters and Consultants)